Kesarwani M, et al. (2017) Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia. Nat Med 23(4):472-482
Paste the following link
Lists
This AllelePublication isn't in any lists. Upload a list.